Northstar Group, Inc. Abbott Laboratories Transaction History

Northstar Group, Inc.

$570 Million
Q3 2024

A detailed history of Northstar Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Northstar Group, Inc. holds 6,654 shares of ABT stock, worth $763,613. This represents 0.13% of its overall portfolio holdings.

Number of Shares

6,654

Previous 6,825 2.51%

Holding current value

$763,613

Previous $709,000 6.91%

% of portfolio

0.13%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$100.07 - $118.13 $17,111 - $20,200	-171 Reduced 2.51%	6,654 $758,000
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $14,700 - $17,995	-163 Reduced 2.33%	6,825 $751,000
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $9,553 - $11,462	-100 Reduced 1.41%	6,988 $676,000
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $12,093 - $13,474	120 Added 1.72%	7,088 $772,000
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $11,597 - $13,605	-122 Reduced 1.72%	6,968 $0
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $105,371 - $122,000	-1,089 Reduced 13.31%	7,090 $687,000
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $6,157 - $7,508	-54 Reduced 0.66%	8,179 $968,000
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $11,784 - $14,428	-102 Reduced 1.22%	8,233 $1.16 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $7,466 - $8,259	-64 Reduced 0.76%	8,335 $985,000
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $7,934 - $9,339	75 Added 0.9%	8,399 $974,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $18,829 - $22,183	173 Added 2.12%	8,324 $997,000
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $210 - $228	2 Added 0.02%	8,151 $892,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $8,889 - $10,795	-97 Reduced 1.18%	8,149 $887,000
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $6,202 - $7,938	-81 Reduced 0.97%	8,246 $754,000
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $125 - $183	2 Added 0.02%	8,327 $657,000
Q4 2019 Jan 21, 2020	SELL	$78.51 - $87.4 $18,292 - $20,364	-233 Reduced 2.72%	8,325 $723,000
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $14,813 - $16,061	-181 Reduced 2.07%	8,558 $716,000
Q2 2019 Jul 12, 2019	BUY	$72.88 - $85.0 $218 - $255	3 Added 0.03%	8,739 $735,000
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $26,289 - $31,783	-397 Reduced 4.35%	8,736 $698,000
Q4 2018 Jan 22, 2019	SELL	$65.56 - $74.27 $9,440 - $10,694	-144 Reduced 1.55%	9,133 $661,000
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $8,939 - $10,783	-147 Reduced 1.56%	9,277 $681,000
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $172 - $190	3 Added 0.03%	9,424 $575,000
Q1 2018 Apr 13, 2018	BUY	$56.27 - $63.62 $168 - $190	3 Added 0.03%	9,421 $565,000
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $9,501 - $10,172	-177 Reduced 1.84%	9,418 $537,000
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $461,135 - $514,675	9,595	9,595 $512,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.

Account

Northstar Group, Inc. Abbott Laboratories Transaction History